TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17908055
Drug: Sequential vaccination
Normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sequential vaccination
Study: 15516645
Drug: Diethylcarbamazine and
Normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Diethylcarbamazine and albendazole therapy (DEC/ALB)
Study: 7639972
Drug: Intravenous ganciclovir
Normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous ganciclovir 5 mg/kg once daily infused over 1 h
Study: 11216491
Drug: Isoflavone tablets
Normalized name: Soy isoflavones
DrugBank: Isoflavone (DB12007)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Isoflavone tablets
Study: 12143204
Drug: Intravenous allopurinol
Normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous allopurinol
Study: 20864251
Drug: Intravesical botulinum
Normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intravesical botulinum toxin type A (BoNTA) injection, >100 U
Study: 8435323
Drug: Oxymetholone 2
Normalized name: Oxymetholone
DrugBank: Oxymetholone (DB06412)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oxymetholone 2 mg/kg/d p.o. daily for 4 months
Study: 2991817
Drug: Org 2766
Normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Org 2766 (synthetic ACTH 4-9 analog), administered for 6 months
Study: 7191300
Drug: triamterene preparation
Normalized name: Triamterene
DrugBank: Triamterene (DB00384)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: triamterene preparation 2
Study: 10331109
Drug: Pindolol treatment
Normalized name: Pindolol
DrugBank: Pindolol (DB00960)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Pindolol treatment
Study: 17098754
Drug: Intracoronary infusion
Normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intracoronary infusion of bone-marrow-derived progenitor cells (BMCs)
Study: 9498433
Drug: Zalcitabine (dideoxycytidine)
Normalized name: ZALCITABINE (DIDEOXYCYTIDINE,ddC)
DrugBank: Zalcitabine (DB00943)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Zalcitabine (dideoxycytidine) monotherapy
Study: 29499855
Drug: PF-03463275 40
Normalized name: selenious acid
DrugBank: Selenious acid (DB11127)
Approvals — FDA: no, EMA: no, PMDA: no
Description: PF-03463275 40 mg twice a day
Study: 24809408
Drug: Oral glutamine
Normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral glutamine (GL) supplementation for 7 days
Study: 16107437
Drug: Daily tenofovir
Normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Daily tenofovir HIV prophylaxis
Study: 19503774
Drug: Active-assisted stretching
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active-assisted stretching program (AA), performed twice weekly for eight weeks
Study: 23382539
Drug: Cardiovascular polypill
Normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Cardiovascular polypill (aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg) taken in the evening
Study: 23069363
Drug: Pedometer-based Green
Normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Pedometer-based Green Prescription
Study: 19018783
Drug: Low-dose flutamide
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose flutamide (62.5 mg/day; 21/28 days)
Study: 26825666
Drug: Probiotic capsule
Normalized name: GNP Probiotic Capsule
DrugBank: Bifidobacterium longum (DB19248)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Probiotic capsule containing four bacterial strains
Study: 30136707
Drug: Fluticasone propionate
Normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Fluticasone propionate nasal spray at 200 microgram once daily for 3 months
Study: 26391671
Drug: Clomiphene citrate
Normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Clomiphene citrate (CC) + low-dose ethinyl estradiol (EE) (0.05 mg daily for 5 days)
Study: 26391671
Drug: Clomiphene citrate
Normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Clomiphene citrate (CC) + placebo
Study: 8977237
Drug: Granulocyte colony-stimulating
Normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Granulocyte colony-stimulating factor (G-CSF) plus stem cell factor (SCF)
Study: 6135507
Drug: Amobarbital sodium
Normalized name: Amobarbital Sodium
DrugBank: Amobarbital (DB01351)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Amobarbital sodium (100 mg)
Study: 11738299
Drug: Aspirin (ASA)
Normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Aspirin (ASA) nonusers
Study: 9793614
Drug: Rectal administration
Normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Rectal administration of tramadol suppositories (100 mg)
Study: 2422461
Drug: Intravenous digoxin
Normalized name: Digoxin
DrugBank: Digoxin (DB00390)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous digoxin (definite infarction subgroup)
Study: 8382969
Drug: Interferon-alpha (IFN-alpha)
Normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Interferon-alpha (IFN-alpha) therapy (2 x 10(6) IU daily for a month, then every other day for 5 months)
Study: 8610733
Drug: Interferon-alpha (IFN-alpha)
Normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Interferon-alpha (IFN-alpha) therapy
Study: 22721608
Drug: Estradiol gel
Normalized name: ESTRADIOL 1 mg in 1 g TOPICAL GEL [Estradiol Gel]
DrugBank: Estradiol acetate (DB13952)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Estradiol gel (2mg)
Study: 801352
Drug: Low-dose heparin
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose heparin (LDH)
Study: 6925576
Drug: Cimetidine (oral)
Normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Cimetidine (oral)
Study: 25295804
Drug: C1 inhibitor
Normalized name: C1 INHIBITOR
DrugBank: Conestat alfa (DB09228)
Approvals — FDA: no, EMA: yes, PMDA: no
Description: C1 inhibitor (C1 INH‐nf; human) 1000 U intravenous injections every 3-4 days for 12 weeks
Study: 22145448
Drug: Recombinant human
Normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Recombinant human growth hormone (rhGH)
Study: 31840388
Drug: Post-treatment sun
Normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Post-treatment sun protection
Study: 14567499
Drug: L-type Ca
Normalized name: VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1C
DrugBank: MEM 1003 (DB05547)
Approvals — FDA: no, EMA: no, PMDA: no
Description: L-type Ca channel blocker (nifedipine CR)
Study: 10423075
Drug: Active treatment
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active treatment (nitrendipine, with possible addition of enalapril and hydrochlorothiazide)
Study: 17558827
Drug: Medication compliance
Normalized name: ribavirin
DrugBank: Ribavirin (DB00811)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Medication compliance
Study: 16923452
Drug: Colesevelam HCl
Normalized name: colesevelam HCl
DrugBank: Colesevelam (DB00930)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Colesevelam HCl (3.75 g/day for 6 weeks)
Study: 30767047
Drug: Streptococcus salivarius
Normalized name: Streptococcus salivarius
DrugBank: Streptococcus salivarius (DB19274)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray
Study: 28939004
Drug: Prednisone 10mg
Normalized name: PREDNISONE 10MG TAB
DrugBank: Prednisone acetate (DB14646)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Prednisone 10mg daily
Study: 17446716
Drug: Oral administration
Normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral administration of lutein
Study: 27893045
Drug: Chlorthalidone vs
Normalized name: Chlorthalidone
DrugBank: Chlorthalidone (DB00310)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Chlorthalidone vs Lisinopril
Study: 11740759
Drug: Adjusted low-dose
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Adjusted low-dose warfarin (INR 1.4-1.8)
Study: 17627241
Drug: Conventional CsA
Normalized name: CsA
DrugBank: Cyclosporine (DB00091)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Conventional CsA triple therapy without induction
Study: 23585997
Drug: Adjunctive aripiprazole
Normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Adjunctive aripiprazole
Study: 22695489
Drug: Almorexant 400
Normalized name: Nemorexant
DrugBank: Daridorexant (DB15031)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Almorexant 400 mg
Study: 6357901
Drug: Xenon-arc photocoagulation
Normalized name: xenon
DrugBank: Xenon (DB13453)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Xenon-arc photocoagulation treatment in one eye
Study: 1507019
Drug: Therapies evaluated
Normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Therapies evaluated based on actual clinical changes rather than presumed etiologic factors.
Study: 18515447
Drug: THC 8
Normalized name: THC
DrugBank: Dronabinol (DB00470)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: THC 8 mg
Study: 30185793
Drug: THC 8
Normalized name: THC
DrugBank: Dronabinol (DB00470)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: THC 8 mg + CBD 16 mg
Study: 26333723
Drug: Intra-aortic balloon
Normalized name: somatropin
DrugBank: Somatotropin (DB00052)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intra-aortic balloon pump (IABP) treatment
Study: 10952480
Drug: Methylene blue
Normalized name: Methylene Blue
DrugBank: Methylene blue (DB09241)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Methylene blue with mesna (100 mg)
Study: 17332177
Drug: Varicella vaccine
Normalized name: Varicella vaccine
DrugBank: Varicella zoster vaccine (live/attenuated) (DB10318)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Varicella vaccine
Study: 20399899
Drug: Chondroitin sulphate
Normalized name: Chondroitin sulphate
DrugBank: Chondroitin sulfate (DB09301)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Chondroitin sulphate (CS) 800 mg daily for 3 months
Study: 29572284
Drug: IV aminophylline
Normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
Approvals — FDA: no, EMA: no, PMDA: no
Description: IV aminophylline 250 mg
Study: 8334029
Drug: Calcium carbonate
Normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Calcium carbonate (maximal dosage of 1 g x 3)
Study: 12368690
Drug: Methylprednisolone 30
Normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Methylprednisolone 30 mg/kg/dose x3
Study: 28220020
Drug: ICR +
Normalized name: Icrucumab
DrugBank: Icrucumab (DB14824)
Approvals — FDA: no, EMA: no, PMDA: no
Description: ICR + CAP (12 mg/kg IV, days 1 and 8; 1,000 mg/m2 orally twice daily, days 1-14)
Study: 27125345
Drug: RIX4414 vaccine
Normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
Approvals — FDA: no, EMA: no, PMDA: no
Description: RIX4414 vaccine
Study: 14767020
Drug: Beta 2-agonist
Normalized name: 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN
DrugBank: Hydroxypropyl betadex (DB15379)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Beta 2-agonist (salbutamol)
Study: 16231342
Drug: Mirror Exposure
Normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Mirror Exposure (ME) therapy
Study: 18806065
Drug: Automated bolus
Normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Automated bolus doses of 5 mL every hour of 0.125% levobupivacaine for 24 h
Study: 3375787
Drug: Lyophilized vaccine
Normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Lyophilized vaccine reconstituted in a buffer solution
Study: 3375787
Drug: Initially marketed
Normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Initially marketed formulation (2 bicarbonate capsules + vaccine capsule)
Study: 11144399
Drug: Cefdinir 14
Normalized name: Cefdinir
DrugBank: Cefdinir (DB00535)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Cefdinir 14 mg/kg once-daily
Study: 11259933
Drug: Topically applied
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Topically applied medicine (Control group B)
Study: 26324250
Drug: Nicotine concentration
Normalized name: Nicotine
DrugBank: Nicotine (DB00184)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nicotine concentration of 0 mg/mL
Study: 1172599
Drug: digoxin tablets
Normalized name: Digoxin Tablets
DrugBank: Digoxin (DB00390)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: digoxin tablets (Digacin¿)
Study: 6089652
Drug: Intranasal human
Normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intranasal human interferon-alpha 2 (HuIFN-alpha 2)
Study: 17545139
Drug: Video intervention
Normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Video intervention (set of 10 videos, workbook, weekly telephone coaching sessions)
Study: 19621690
Drug: 6 g
Normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
Approvals — FDA: no, EMA: no, PMDA: no
Description: 6 g AzOAB: Azithromycin 500 mg twice daily for 6 days and Omeprazole 20 mg, Amoxicillin 1 g, Bismuth 240 mg all twice daily for 2 weeks
Study: 11863118
Drug: Oral etoposide
Normalized name: Etoposide
DrugBank: Etoposide (DB00773)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Oral etoposide
Study: 21765273
Drug: bimanual intensive
Normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: bimanual intensive rehabilitation treatment (IRP)
Study: 12807340
Drug: Hypericum cream
Normalized name: Hypericum oil
DrugBank: St. John's Wort (DB01323)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Hypericum cream (1.5% hyperforin)
Study: 31830835
Drug: Peri-conceptional progesterone
Normalized name: Progesterone
DrugBank: Progesterone (DB00396)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Peri-conceptional progesterone treatment
Study: 1543140
Drug: Sustained-release diltiazem
Normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Sustained-release diltiazem (180 mg twice daily)
Study: 1709020
Drug: Terfenadine tablet
Normalized name: terfenadine Oral Tablet
DrugBank: Terfenadine (DB00342)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Terfenadine tablet 60 mg twice/day
Study: 6351889
Drug: Inhaled reproterol
Normalized name: reproterol
DrugBank: Reproterol (DB12846)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Inhaled reproterol (1 mg)
Study: 11562580
Drug: Uncoated extracorporeal
Normalized name: nicotine
DrugBank: Nicotine (DB00184)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Uncoated extracorporeal circulation with full dose systemic heparinization (Group A)
Study: 26283139
Drug: Low-dose intravenous
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose intravenous alteplase (0.6 mg/kg body weight)
Study: 25115901
Drug: Vaniprevir 600
Normalized name: Vaniprévir
DrugBank: Vaniprevir (DB11929)
Approvals — FDA: no, EMA: no, PMDA: yes
Description: Vaniprevir 600 mg plus PR
Study: 29771966
Drug: Sodium bicarbonate
Normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Sodium bicarbonate (SB) ingestion up to 150 mg∙kg‐1 in a progressive-dose regimen for 10 days
Study: 16603964
Drug: L-NMMA effect
Normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
Approvals — FDA: no, EMA: no, PMDA: no
Description: L-NMMA effect on RCF
Study: 25163547
Drug: Biological mesh
Normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Biological mesh closure of the pelvic floor after eAPR
Study: 16319785
Drug: Iyengar yoga
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Iyengar yoga classes (2 weekly 90-min sessions for 3 months)
Study: 12920661
Drug: Ultratard insulin
Normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Ultratard insulin
Study: 3293255
Drug: Chloroquine phosphate
Normalized name: Chloroquine Phosphate
DrugBank: Chloroquine (DB00608)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Chloroquine phosphate and ibuprofen
Study: 26711799
Drug: Prolonged 60-second
Normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Prolonged 60-second delay for VT therapy ≥170 (Treatment arm C)
Study: 3512394
Drug: Porcine insulin
Normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Porcine insulin
Study: 10581593
Drug: Insulin clamp
Normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Insulin clamp alone (control)
Study: 24267730
Drug: Exemestane (EXE)
Normalized name: Exemestane
DrugBank: Exemestane (DB00990)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Exemestane (EXE) 25 mg/d
Study: 31105703
Drug: Golimumab (GM)
Normalized name: Golimumab
DrugBank: Golimumab (DB06674)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Golimumab (GM) treatment
Study: 24648506
Drug: Amoxicillin thrice
Normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Amoxicillin thrice daily (50 mg/kg/day)
Study: 20512273
Drug: Intravenous fentanyl
Normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Intravenous fentanyl (100 microg)
Study: 26783268
Drug: Carbon nanoparticle
Normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Carbon nanoparticle suspension (CNPS)
Study: 12925476
Drug: Intrathecal diamorphine
Normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intrathecal diamorphine (all doses)
Study: 25779750
Drug: Both apremilast
Normalized name: Apremilast
DrugBank: Apremilast (DB05676)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Both apremilast doses
Study: 8646873
Drug: Fluticasone propionate
Normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Fluticasone propionate ointment, 0.005%
Study: 8635374
Drug: Mitomycin therapy
Normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Mitomycin therapy
Study: 19631949
Drug: Pregabalin (PGB)
Normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Pregabalin (PGB) 150-600 mg/day
Study: 9602222
Drug: Alcoholic solution
Normalized name: Alcohol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Alcoholic solution under occlusion
Study: 20637971
Drug: Linagliptin single
Normalized name: Linagliptin
DrugBank: Linagliptin (DB08882)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Linagliptin single doses (1, 2.5, 5, 10 mg)
Study: 20637971
Drug: Linagliptin multiple
Normalized name: Linagliptin
DrugBank: Linagliptin (DB08882)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Linagliptin multiple doses (2.5, 5, 10 mg)
Study: 15834325
Drug: In Clinic
Normalized name: Stopain Clinical
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: In Clinic Exercise Group (nonelastic sacroiliac belt, oral/written information, and participation in a training program)
Study: 24816936
Drug: Low-dose unenhanced
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose unenhanced ungated chest CT for AVC measurement
Study: 24816936
Drug: Low-dose unenhanced
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose unenhanced ungated chest CT for MC measurement
Study: 15023462
Drug: Commercial reference
Normalized name: iodine
DrugBank: Iodine (DB05382)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Commercial reference tablet
Study: 30341175
Drug: Pharmacy intervention
Normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Pharmacy intervention (pharmacist visit during second or third chemotherapy infusion)
Study: 2646469
Drug: Intensified insulin
Normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intensified insulin therapy (IIT)
Study: 7839898
Drug: Cytosine arabinoside
Normalized name: Cytosine arabinoside
DrugBank: Cytarabine (DB00987)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Cytosine arabinoside 100 mg/m2 subcutaneously (sc) 12 hourly for days 1‐5
Study: 21419776
Drug: Canary pox
Normalized name: canary feather extract
DrugBank: Serinus canaria feather (DB10857)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Canary pox recombinant vaccine
Study: 31874865
Drug: Usual practice
Normalized name: menthol
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Usual practice (restrictive diet, physical activity, and thermal spa treatment)
Study: 1300518
Drug: Discolored lenses
Normalized name: Salix discolor pollen
DrugBank: Salix discolor pollen (DB10753)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Discolored lenses (amber lens discoloration achieved using human‐worn 55% water hydrophilic contact lenses heated in a 1% potassium sorbate, low pH saline solution)
Study: 25033643
Drug: Psychological nursing
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Psychological nursing intervention and analgesic drug treatment
Study: 16420547
Drug: Levofloxacin combined
Normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Levofloxacin combined with standard treatment